EMILIO BOUZA SANTIAGO-rekin lankidetzan egindako argitalpenak (140)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  5. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection

    Open Forum Infectious Diseases, Vol. 10, Núm. 2

2022

  1. Abiotrophia spp. and Granulicatella spp. Infective Endocarditis: A Contemporary Perspective

    Frontiers in bioscience (Elite edition), Vol. 14, Núm. 3, pp. 23

  2. Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic

    Frontiers in Medicine, Vol. 9

  3. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  4. Exhaustive diagnosis of breast implants with capsular contracture: The microbiology laboratory as a major support

    Journal of Plastic, Reconstructive and Aesthetic Surgery, Vol. 75, Núm. 9, pp. 3085-3093

  5. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  6. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Infective Endocarditis in Patients on Chronic Hemodialysis

    Journal of the American College of Cardiology, Vol. 77, Núm. 13, pp. 1629-1640

  3. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  4. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

  5. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  6. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

  7. Sample pooling is efficient in PCR testing of SARS-CoV-2: a study in 7400 healthcare professionals

    Diagnostic Microbiology and Infectious Disease, Vol. 100, Núm. 1

  8. The challenge of COVID-19 for a Clinical Microbiology Department

    Diagnostic Microbiology and Infectious Disease, Vol. 101, Núm. 2

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494